Literature DB >> 33244497

PSEUDOHYPOPHOSPHATEMIA IN A PATIENT WITH MULTIPLE MYELOMA.

Lawrence Wen Wu, Tak-Shun Choi, Monica Barbosa, Hyemi Chong, Ashley Garland Wallace Wu, Kyaw K Soe.   

Abstract

OBJECTIVE: To discuss the diagnosis and management of paraprotein interference in the setting of multiple myeloma (MM).
METHODS: We discuss the evaluation of hypophosphatemia in a patient with MM and present a review of the relevant literature.
RESULTS: Our patient, who had a history of MM, was found to have persistently undetectable serum phosphate which did not respond to aggressive phosphate replacement. His clinical condition was not consistent with severe phosphate depletion and hence paraprotein interference secondary to MM was suspected. Re-analyzation of samples on a different machine showed normal serum inorganic phosphate levels.
CONCLUSION: Paraprotein interference from MM causing pseudohypophosphatemia can be overlooked and lead to unnecessary treatment. Recognition of this phenomenon is important to all clinicians, especially in light of potential complications of unnecessary treatment.
Copyright © 2020 AACE.

Entities:  

Year:  2020        PMID: 33244497      PMCID: PMC7685403          DOI: 10.4158/ACCR-2020-0389

Source DB:  PubMed          Journal:  AACE Clin Case Rep        ISSN: 2376-0605


  13 in total

1.  Pseudohypercreatininemia due to positive interference in enzymatic creatinine measurements caused by monoclonal IgM in patients with Waldenström's macroglobulinemia.

Authors:  K M Hummel; N von Ahsen; R B Kühn; U Kaboth; R W Grunewald; M Oellerich; G A Müller
Journal:  Nephron       Date:  2000-10       Impact factor: 2.847

2.  Paraprotein interference in automated chemistry analyzers.

Authors:  Agata Smogorzewska; James G Flood; William H Long; Anand S Dighe
Journal:  Clin Chem       Date:  2004-09       Impact factor: 8.327

3.  Pseudohyponatremia in multiple myeloma.

Authors:  Prithvi Giri; Jacob George; A K Gupta; R Gupta
Journal:  J Assoc Physicians India       Date:  2010-08

4.  Spurious hypophosphatemia in a patient with multiple myeloma.

Authors:  M Loghman-Adham; D Walton; P H Iverius; A Deiss; J A Knight; A K Cheung
Journal:  Am J Kidney Dis       Date:  1997-10       Impact factor: 8.860

5.  Pseudohyperphosphatemia in multiple myeloma.

Authors:  M Mavrikakis; G Vaiopoulos; P Athanassiades; L Antoniades; C Papamichael; M A Dimopoulos
Journal:  Am J Hematol       Date:  1996-02       Impact factor: 10.047

Review 6.  Hypophosphatemia: an update on its etiology and treatment.

Authors:  André Gaasbeek; A Edo Meinders
Journal:  Am J Med       Date:  2005-10       Impact factor: 4.965

7.  Spurious hypophosphatemia associated with multiple myeloma.

Authors:  J A Caras
Journal:  Endocr Pract       Date:  1997 May-Jun       Impact factor: 3.443

8.  Pseudohyperphosphatemia in a patient with multiple myeloma.

Authors:  Constantin B Marcu; Mark Hotchkiss
Journal:  Conn Med       Date:  2004-02

Review 9.  Hypophosphatemia associated with paraproteinemia: a case report and review of the literature.

Authors:  Sarah Kerr; Joshua Kindt; Sumanth R Daram
Journal:  WMJ       Date:  2007-12

10.  Pseudohyperphosphatemia in a patient with multiple myeloma.

Authors:  Yonggu Lee; Taiyon Koo; Joo-Hark Yi; Jung-Hye Choi; Sang-Woong Han; Ile-Kyu Park; Ho-Jung Kim
Journal:  Electrolyte Blood Press       Date:  2007-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.